These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 14694892)
1. Fingerprinting cancer development. Potera C Environ Health Perspect; 2003 Aug; 111(11):A572. PubMed ID: 14694892 [No Abstract] [Full Text] [Related]
2. Early detection of epithelial ovarian cancer using a proteomics-based protein-profiling approach combined with a novel selection strategy. Kothandaraman N; Bajic VB; Loganath A; Koh S; Ng J; Choolani M; Razvi K Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S59-60. PubMed ID: 15651211 [No Abstract] [Full Text] [Related]
4. Clinical proteomics--insights into pathologies and benefits for patients. Banks R; Selby P Lancet; 2003 Aug; 362(9382):415-6. PubMed ID: 12927423 [No Abstract] [Full Text] [Related]
5. [Proteomics and biomarkers for detection of ovarian cancer]. Kacerovský M; Tambor V; Lenco J; Tosner J Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513 [TBL] [Abstract][Full Text] [Related]
6. New routes for drug discovery. Jain KK Drug Discov Today; 2002 Sep; 7(17):900-2. PubMed ID: 12546932 [No Abstract] [Full Text] [Related]
7. Debate rages over proteomic patterns. Garber K J Natl Cancer Inst; 2004 Jun; 96(11):816-8. PubMed ID: 15173258 [No Abstract] [Full Text] [Related]
8. New technologies in cancer. Protein microarrays for biomarker discovery. Matarraz S; González-González M; Jara M; Orfao A; Fuentes M Clin Transl Oncol; 2011 Mar; 13(3):156-61. PubMed ID: 21421460 [TBL] [Abstract][Full Text] [Related]
9. Can the acute-phase reactant proteins be used as cancer biomarkers? Pang WW; Abdul-Rahman PS; Wan-Ibrahim WI; Hashim OH Int J Biol Markers; 2010; 25(1):1-11. PubMed ID: 20155712 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers for the early detection of cancer: an inflammatory concept. Roy HK; Khandekar JD Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302 [No Abstract] [Full Text] [Related]
11. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Fung ET; Yip TT; Lomas L; Wang Z; Yip C; Meng XY; Lin S; Zhang F; Zhang Z; Chan DW; Weinberger SR Int J Cancer; 2005 Jul; 115(5):783-9. PubMed ID: 15704152 [TBL] [Abstract][Full Text] [Related]
13. General keynote: cancer screening: translation of principles into practice. Kramer BS Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S71-4; discussion S80-3. PubMed ID: 12586090 [No Abstract] [Full Text] [Related]
14. A designed peptide chip: protein fingerprinting technology with a dry peptide array and statistical data mining. Usui K; Tomizaki KY; Mihara H Methods Mol Biol; 2009; 570():273-84. PubMed ID: 19649599 [TBL] [Abstract][Full Text] [Related]
15. [Study of a serum protein fingerprint diagnostic model in patients with hypertensive disorder complicating pregnancy]. gong LY; Zhang ZY; Zheng YH; Zhang JZ Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):822-5. PubMed ID: 18476515 [TBL] [Abstract][Full Text] [Related]
16. Serum proteomic pattern analysis for early cancer detection. Liu Y Technol Cancer Res Treat; 2006 Feb; 5(1):61-6. PubMed ID: 16417403 [TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric compatibility of Deep Purple and SYPRO Ruby total protein stains for high-throughput proteomics using large-format two-dimensional gel electrophoresis. Nock CM; Ball MS; White IR; Skehel JM; Bill L; Karuso P Rapid Commun Mass Spectrom; 2008; 22(6):881-6. PubMed ID: 18293286 [TBL] [Abstract][Full Text] [Related]
18. New effort to develop molecular tools for early cancer detection under way. Kuehn BM JAMA; 2005 Feb; 293(7):783-5. PubMed ID: 15713753 [No Abstract] [Full Text] [Related]